lilly tirzepatide news

Lilly weight-loss drug copycats dealt blow

Lilly’s Tirzepatide No Longer on FDA Drug Shortage List

BMO Capital Markets analyst Evan Seigerman called it “another positive indication” for Eli Lilly, whose top-selling diabetes and weight loss drugs are gaining market share as manufacturing continues to expand,

Hosted on MSN · 20h

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.

The Washington Post · 16h

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.

35m

NHS proposes phased launch for Eli Lilly’s Mounjaro

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

Lilly to invest $4.5 bln on new facility to scale-up pipeline drug production

U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center for advanced manufacturing and ...

23h

Eli Lilly & Co: Resolution of Tirzepatide Supply Issue Bolsters Buy Rating

Deutsche Bank analyst James Shin maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price target of ...

BMJ2h

NHS England consults on rolling out obesity injection tirzepatide to meet demand

NHS leaders are considering a phased rollout of the obesity injection tirzepatide (Mounjaro, Eli Lilly) because of potentially high demand. The National Institute for Health and Care Excellence (NICE) ...

Daily Reporter20h

Eli Lilly’s weight-loss drugs no longer in shortage, FDA says

Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics